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Abstract
Background: Melanocortin, through its distinct receptor sub-
types, has many different effects. Receptor-selective ligands are
required to reduce the undesirable effects of melanocortin. To
investigate which conformation is preferable to a given melano-
cortin receptor subtype, a structural and functional analysis of the
ligand^receptor interactions was made by studying the biological
activity, the nuclear magnetic resonance structures, and the
patterns of the ligand^receptor interaction for each receptor
subtype by homology modeling analysis.
Results : Among the several analogues examined, [Gln6]K-
melanocyte-stimulating hormone (MSH)-ND was found to have
10 000 times less biological activity than K-MSH-ND for the
MC1R, whereas, the potencies of both oligopeptides were
comparable in both the melanocortin-3 receptor (MC3R) and
MC4R. [Gln6]K-MSH-ND exhibited a type IP L-turn that was
similar to the type I L-turn structure of K-MSH-ND. However, a
remarkable structural difference was observed with respect to the
side chain orientations of the sixth and seventh residues of
[Gln6]K-MSH-ND, which were found to be mirror images of K-
MSH-ND. By homology modeling analysis, the His6 of K-MSH-
ND was found to interact with the TM2 regions of all three
receptors (Glu94 of MC1R, Glu94 of MC3R, and Glu100 of
MC4R), but [Gln6]K-MSH-ND did not. The phenyl ring of the D-
Phe7 residue of [Gln6]K-MSH-ND revealed an interaction with the
TM3 regions of both the MC3R and MC4R (Ser122 of MC3R or
Ser127 of MC4R). However, in the MC1R, these serine residues
corresponded to Val122, which contains two methyl groups that
induce steric hindrance with D-Phe7 of [Gln6]K-MSH-ND. This is
a possible explanation for the biological activity of [Gln6]K-MSH-
ND for the MC1R being significantly lower than that for either
the MC3R or MC4R.
Conclusions: Minimization of the MC1R selectivity whilst
preserving its comparable potency for both the MC3R and
MC4R could be achieved by modifying the D-Phe7 orientation
of K-MSH-ND, while maintaining the ‘type I L-turn’-like struc-
ture. ß 2001 Elsevier Science Ltd. All rights reserved.
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erating activity; Nuclear magnetic resonance; Type I L-turn; Ho-
mology modeling
1074-5521 / 01 / $ ^ see front matter ß 2001 Elsevier Science Ltd. All rights reserved.
PII: S 1 0 7 4 - 5 5 2 1 ( 0 1 ) 0 0 0 5 7 - 6
Abbreviations: MC1R, melanocortin-1 receptor; MC3R, melanocortin-3 receptor; MC4R, melanocortin-4 receptor; MSH, melanocyte-stimulating hor-
mone; Ahx, K-aminohexanoic acid; CHO, Chinese hamster ovary cell line; NMR, nuclear magnetic resonance; REM, restraints energy minimization;
TOCSY, total correlation spectroscopy; ROESY, rotating-frame Overhauser e¡ect spectroscopy; NOESY, nuclear Overhauser e¡ect spectroscopy; DG,
distance geometry; DQF-COSY, double-quantum-¢ltered correlated spectroscopy; TM, transmembrane
1 These two authors contributed equally to this work.
* Corresponding author.
E-mail addresses: lsk@yumc.yonsei.ac.kr (S.-K. Lim), cjyoon@www.cuk.ac.kr (C.-J. Yoon), jahyunb@yumc.yonsei.ac.kr (J.-H. Baik),
wlee@nestis.yonsei.ac.kr (W. Lee).
CHBIOL 122 10-9-01 Cyaan Magenta Geel Zwart
Chemistry & Biology 8 (2001) 857^870
www.elsevier.com/locate/chembiol
1. Introduction
Melanocortins, including K-melanocyte-stimulating hor-
mone (MSH) have been implicated in a variety of physio-
logic functions, such as skin pigmentation, learning, mem-
ory, analgesic and anti-in£ammatory e¡ects, the regulation
of blood pressure, immune modulation and food intake
[1^6]. The cloning of ¢ve melanocortin receptor subtypes
has facilitated research in this ¢eld and provided the tools
for a systematic study of the molecular mechanisms in-
volved in the physiologic e¡ects of these subtypes [7^13].
As melanocortin has many di¡erent e¡ects related to the
distinct receptor subtypes, a selective ligand for a given
receptor subtype is required to reduce its undesirable ef-
fects. Hence, the structural and functional analysis of the
ligand^receptor interactions of melanocortin has assumed
greater importance.
In a previous nuclear magnetic resonance (NMR) study
[14], it was shown that the core residues of His6-(D-Phe) 7-
Arg8-Trp9 of K-MSH-ND formed a stable structure called
the type I L-turn, and that substitution of the His6 residue
with other amino acid residues resulted in remarkable
structural changes. The receptor binding a⁄nity and the
cAMP-generating activity of the substitutes at both the
MC3R and MC4R were also signi¢cantly decreased.
Therefore, it is proposed in this study that the structure
of the type I L-turn, which is composed of core residues,
might be important for K-MSH analogues both to bind
optimally with and to activate both the MC3R and MC4R
[15].
The selectivity and biological potency of a diverse num-
ber of peptides have been determined in terms of the pep-
tide backbone structure and its side chains [16^21]. Has-
kell-Luevano et al. incorporated a methyl group on the L-
carbons of the two aromatic amino acids to identify the
3D orientation of the Phe7 and Trp9 amino acids when
binding to melanocortin-1 receptor (MC1R). They found
that the 3D orientation of these amino acids can a¡ect
both the potencies and the prolonged biological activities
of melanotropin peptides [22]. However, they did not show
how the side chain orientations of the melanocortin phar-
macophores a¡ect the ligand^receptor interactions and
biological activity.
In a previous NMR study, [Gln6]K-MSH-ND was
found to have a similar backbone structure to the type I
L-turn of K-MSH-ND, the so-called type IP L-turn. In
contrast, the side chains of the sixth and seventh residues
of [Gln6]K-MSH-ND were mirror images of the respective
K-MSH-ND residues. The biological potency of [Gln6]K-
MSH-ND for MC1R was signi¢cantly lower than that of
K-MSH-ND. However, this was not the case for either the
MC3R or the MC4R. These ¢ndings imply that di¡erences
in the side chain orientation of both oligopeptides, which
show isomeric conformations, can have a remarkable af-
fect on the biological potency according to receptor sub-
type. This study aimed to determining how melanocortin
interacts with a given receptor subtype, and how the dif-
ferences in the side chain orientation a¡ect selectivity. This
was accomplished by combining the NMR structural char-
acteristics, the receptor binding a⁄nities, and the cAMP-
generating activity of both K-MSH-ND and [Gln6]K-
MSH-ND, with the results obtained from the receptor
homology modeling analysis results.
2. Results
To investigate the relationship between the structure
and function of the melanocortins, several K-MSH ana-
logues were synthesized (Table 1), and their biological
activities were tested. In addition, an attempt was made
to further understand their structural characteristics and
the possible structural features of the melanocortin recep-
tor subtypes based upon their ligand^receptor interactions.
2.1. Receptor binding activity of K-MSH analogues
The [K-aminohexanoic acid (Ahx)4]K-MSH, NDP-MSH
Table 1
Sequences of the K-MSH analogues used in this study
Peptides Position
1 2 3 4 5 6 7 8 9 10 11 12 13
[Ahx4]K-MSH Ser Tyr Ser Ahx Glu His Phe Arg Trp Gly Lys Pro Val
NDP-MSH Ser Tyr Ser Ahx Glu His D-Phe Arg Trp Gly Lys Pro Val
K-MSH-ND Ahx Asp His D-Phe Arg Trp Lys
[Gln6]K-MSH-ND Ahx Asp Gln D-Phe Arg Trp Lys
[Trp6]K-MSH-ND Ahx Asp Trp D-Phe Arg Trp Lys
[Asn6]K-MSH-ND Ahx Asp Asn D-Phe Arg Trp Lys
[Arg6]K-MSH-ND Ahx Asp Arg D-Phe Arg Trp Lys
[Lys6]K-MSH-ND Ahx Asp Lys D-Phe Arg Trp Lys
[Tyr6]K-MSH-ND Ahx Asp Tyr D-Phe Arg Trp Lys
[Trp6]K-MSH-ND(6^10) Trp D-Phe Arg Trp Lys
[Trp6]K-MSH-ND(6^9) Trp D-Phe Arg Trp
All peptides have an acetyl-group on the N-terminus and an amide group on the C-terminus. The main substituted amino acid residues are shown in
italics.
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and K-MSH-ND binding a⁄nities for the MC1R were
measured to determine the roles of the seventh residue in
the receptor^ligand interaction. As shown in Table 2, the
order of preference was NDP-MSHs [Ahx4]K-MSHsK-
MSH-ND. Their Ki values (nM) at the MC1R were
0.0026 þ 0.0019, 0.0068 þ 0.0011 and 0.0314 þ 0.0198, re-
spectively. A comparison of the binding a⁄nities of the
three analogues revealed a preference for the MC1R as
opposed to the MC3R and MC4R (Fig. 1). Substitution
of the seventh residue, from Phe to D-Phe, induced a re-
markably potentiated selectivity for MC4R. Even though
K-MSH-ND did not show a higher binding a⁄nity than
[Ahx4]K-MSH as was detected for both the MC3R and
MC4R, it still bound to the MC1R quite well.
When the K-MSH-ND His6 residue was substituted with
Gln, Trp, Asn, Arg, Lys or Tyr, as shown in Fig. 1, all the
analogues with the exception of [Arg6]K-MSH-ND showed
a signi¢cantly decreased binding a⁄nity for the MC1R.
The order of their MC1R binding a⁄nities were:
[Arg6]K-MSH-NDsK-MSH-NDE[Lys6]K-MSH-NDs
[Tyr6]K-MSH-NDs [Asn6]K-MSH-NDs [Gln6]K-MSH-
NDs [Trp6]K-MSH-ND, and their Ki values (nM) were
0.0041 þ 0.0014, 0.0314 þ 0.0198, 8.828 þ 3.362, 43.87 þ
16.68, 151.38 þ 20.78, 243.33 þ 29.83 and 392.01 þ 165.70,
respectively. In addition, the Ki values of the two addi-
tionally synthesized peptides, [Trp6]K-MSH-ND and
[Tyr6]K-MSH-ND, were 57.25 þ 11.59 and 36.24 þ 5.22,
respectively, at the MC3R, but 57.60 þ 20.03 and
36.07 þ 6.957, respectively, at the MC4R. From the ob-
served binding a⁄nities of these receptors, it was found
that, with the exception of Arg, the replacement of His6
with the other residues resulted in a 10 000-fold decrease in
the binding a⁄nity for the MC1R, while a reasonable
binding activity was still maintained for both the MC3R
Fig. 1. Receptor binding a⁄nities of the di¡erent K-MSH analogues. The CHO cells over-expressing MC1R, MC3R or MC4R were incubated with a
¢xed concentration of V2 nM 125I-labelled NDP-MSH in the presence of increasing concentrations of K-MSH analogues as indicated. The ordinate
represents the mean Ki values, which were determined using a software package suitable for radioligand binding analysis (GraphPad Prism Program).
Table 2
Ki values (mean þ S.E.M.) of the K-MSH analogues obtained from a computer analysis of the competition curves on the stable transfected CHO cells
over-expressing MC1R, MC3R or MC4R
Ligands Ki (nM)
MC1R MC3R MC4R
[Ahx4]K-MSH 0.0068 þ 0.0011 17.64 þ 5.33 156.69 þ 20.04
NDP-MSH 0.0026 þ 0.0019 0.061 þ 0.012 0.372 þ 0.128
K-MSH-ND 0.0314 þ 0.0198 7.801 þ 1.501 4.405 þ 0.704
[Gln6]K-MSH-ND 243.33 þ 29.83 177.51 þ 19.84 73.64 þ 17.06
[Trp6]K-MSH-ND 392.01 þ 165.70 57.25 þ 11.59 57.60 þ 20.03
[Asn6]K-MSH-ND 151.38 þ 20.78 330.22 þ 60.05 112.57 þ 9.738
[Arg6]K-MSH-ND 0.0041 þ 0.0014 59.75 þ 9.54 37.74 þ 5.504
[Lys6]K-MSH-ND 8.828 þ 3.362 552.02 þ 144.96 156.56 þ 26.72
[Tyr6]K-MSH-ND 43.87 þ 16.68 36.24 þ 5.22 36.07 þ 6.957
[Trp6]K-MSH-ND(6^10) 20.04 þ 4.473 3,837.7 þ 1,486.8 396.82 þ 107.77
[Trp6]K-MSH-ND(6^9) 1.099 þ 0.426 728.37 þ 333.66 490.98 þ 55.93
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and MC4R. Fig. 3A shows that the [Gln6]K-MSH-ND-
binding activity for the MC1R was substantially lower
than that of K-MSH-ND. However, this was not the
case in terms of its relative binding a⁄nities for either
the MC3R or the MC4R.
[Trp6]K-MSH-ND showed the lowest binding activity
for the MC1R. To further investigate whether or not the
shorter analogues could have biological activity, two pep-
tides, [Trp6]K-MSH-ND(6^10) and [Trp6]K-MSH-ND(6^
9), were synthesized by deleting either both the Ahx4
and Asp5 residues only or by deleting them together
with Lys10. Their binding a⁄nities for the MC1R,
MC3R and MC4R were determined. As shown in Table
2, [Trp6]K-MSH-ND(6^10) and [Trp6]K-MSH-ND(6^9)
showed Ki values (nM) of 20.04 þ 4.473 and
1.099 þ 0.426, respectively, for the MC1R,
3837.7 þ 1486.8 and 728.37 þ 333.66, respectively, for the
MC3R, and 396.82 þ 107.77 and 490.98 þ 55.93, respec-
tively, for the MC4R. Compared with [Trp6]K-MSH-
ND, the truncated peptides showed signi¢cantly lower
binding a⁄nities for both the MC3R and MC4R (Fig.
1). The order of preference for the MC3R was [Trp6]K-
MSH-NDs [Trp6]K-MSH-ND(6^9)s [Trp6]K-MSH-ND-
(6^10), and for the MC4R, [Trp6]K-MSH-NDs [Trp6]K-
MSH-ND(6^10)s [Trp6]K-MSH-ND(6^9). However,
[Trp6]K-MSH-ND(6^9) exhibited a higher binding activity
than [Trp6]K-MSH-ND for the MC1R with an order of
preference of [Trp6]K-MSH-ND(6^9)s [Trp6]K-MSH-
ND(6^10)s [Trp6]K-MSH-ND. These results suggested
that the shorter analogue, despite being composed of
Table 3
EC50 values (mean þ S.E.M.) of the K-MSH analogues obtained from a computer analysis of the dose^response curves on the stably transfected CHO
cells over-expressing MC1R, MC3R or MC4R
Ligands EC50(nM)
MC1R MC3R MC4R
[Ahx4]K-MSH 0.00558 þ 0.00131 9.362 þ 1.932 46.040 þ 0.020
NDP-MSH 0.00067 þ 0.00039 0.174 þ 0.052 0.126 þ 0.020
K-MSH-ND 0.00799 þ 0.00451 1.523 þ 0.707 0.780 þ 0.405
[Gln6]K-MSH-ND 96.62 þ 32.276 9.383 þ 4.620 7.880 þ 1.818
[Trp6]K-MSH-ND 387.9 þ 164.10 110.00 þ 35.701 0.812 þ 0.428
[Asn6]K-MSH-ND 16.77 þ 6.944 271.80 þ 21.948 0.799 þ 0.121
[Arg6]K-MSH-ND 1.765 þ 0.800 0.381 þ 0.157 4.858 þ 0.949
[Lys6]K-MSH-ND 6.879 þ 2.650 29.560 þ 11.525 19.890 þ 4.024
[Tyr6]K-MSH-ND 178.8 þ 45.269 76.860 þ 12.088 273.60 þ 259.668
[Trp6]K-MSH-ND(6^10) 1795 þ 189 9 184.80 þ 110.625
[Trp6]K-MSH-ND(6^9) 512.40 þ 64.68 9 11.320 þ 8.957
The values in italics mean that their mature cAMP generation failed to reach the maximum stimulation as shown by other analogues.
‘9’ indicates that the compounds did not show the visible e¡ect on cAMP-generation even at the highest concentration used in this experiments.
Fig. 2. cAMP-generating activity of di¡erent K-MSH analogues. The potencies of the K-MSH analogues are shown as the mean EC50 values. The bars
indicated with ‘R’ show that mature cAMP generation failed to reach the maximum stimulation level shown by other analogues. ‘*’ indicates that the
analogues did not exhibit a signi¢cant e¡ect on cAMP generation even at the highest concentrations indicated.
CHBIOL 122 10-9-01 Cyaan Magenta Geel Zwart
860 Chemistry & Biology 8/9 (2001) 857^870
only four core residues, is still capable of generating a
binding a⁄nity for the MC1R.
2.2. E¡ects of K-MSH analogues on cAMP accumulation
in Chinese hamster ovary (CHO) cells over-expressing
MC1R, MC3R or MC4R
In a manner identical to the binding assay results de-
scribed above, [Ahx4]K-MSH, NDP-MSH and K-MSH-
ND at the MC1R exhibited cAMP-generating activities
in the order NDP-MSHs [Ahx4]K-MSHsK-MSH-ND
(Fig. 2); their corresponding EC50 values (nM) for the
MC1R were 0.00558 þ 0.00131, 0.00067 þ 0.00039 and
0.00799 þ 0.00451, respectively (Table 3). Compared with
their cAMP stimulation at both the MC3R and MC4R, all
these three analogues showed higher biological activity at
the MC1R, which is consistent with the results of the bind-
ing assay.
Substituting His6 for either Gln, Trp, Asn, Arg, Lys or
Tyr brought about reductions in cAMP accumulations,
Fig. 3. Comparison of the biological activities of K-MSH-ND (b) and [Gln6]K-MSH-ND (R) at MC1R, MC3R and MC4R. (A) Competition binding.
The CHO cells over-expressing MC1R, MC3R or MC4R were incubated with a ¢xed concentration of V2 nM 125I-labelled NDP-MSH in the presence
of increasing concentrations of either K-MSH-ND or [Gln6]K-MSH-ND as indicated. The ordinate represents the percentage of the total speci¢c binding
(Bmax). The curves were ¢tted using non-linear regression analysis and a one-site competition model (GraphPad Prism). (B) cAMP-generating activity
assay. The cells stably transfected with MC1R, MC3R or MC4R were treated with various concentrations of K-MSH-ND or [Gln6]K-MSH-ND, and
the intracellular cAMP production was assayed. The ordinate shows folds of the basal (indicated as 10313 M) cAMP level obtained for each curve. The
curves were ¢tted using the sigmoidal dose^response model with a variable slope factor (GraphPad Prism). All curves are representative of two inde-
pendent experiments, and each point represents the mean of three values.
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especially at the MC1R. Their potencies at the MC1R
were in the order: K-MSH-NDE[Arg6]K-MSH-NDs
[Lys6]K-MSH-NDs [Asn6]K-MSH-NDs [Gln6]K-MSH-
NDs [Tyr6]K-MSH-NDs [Trp6]K-MSH-ND, and the
corresponding EC50 values (nM) were 0.00799 þ 0.00451,
1.765 þ 0.800, 6.879 þ 2.650, 16.77 þ 6.944, 96.62 þ 32.276,
178.8 þ 45.269 and 387.9 þ 164.10, respectively (Table 3).
Analogues with positively charged residues at the sixth
position, such as His6, Arg6 and Lys6, produced higher
cAMP-generating activities than the others. Speci¢cally,
[Gln6]K-MSH-ND showed a 10 000-fold reduction in
cAMP-generating activity at the MC1R, which was more
signi¢cant than that observed at either the MC3R or
the MC4R (Fig. 3B). In addition, [Tyr6]K-MSH-ND ex-
hibited EC50 values of 76.860 þ 12.088 at the MC3R, and
273.60 þ 259.668 at the MC4R. The two truncated forms,
[Trp6]K-MSH-ND(6^10) and [Trp6]K-MSH-ND(6^9), did
not show any cAMP-generating activity at the MC3R,
with the former yielding an EC50 value (nM) of 184.80 þ
110.625 at the MC4R and the latter 512.40 þ 64.68 at the
MC1R.
2.3. Solution structures of K-MSH analogues
The restraints energy minimization (REM) average
structures of the K-MSH analogues for receptor^ligand
complex modeling were calculated from the NMR struc-
tures based on the reported data [14,15]. Even though
these ligand structures were derived in the free state,
they were able to explain the key features of the binding
a⁄nity because the more adaptable a ligand structure is,
the greater the likelihood that it can initiate receptor bind-
ing. To compare the backbone conformations of [Gln6]K-
MSH-ND and K-MSH-ND, the REM structure of
[Gln6]K-MSH-ND was superimposed, with speci¢c atten-
tion placed on the Asp5 to Arg8 residues of K-MSH-ND.
As shown in Fig. 4, the solution structures of K-MSH-ND
and [Gln6]K-MSH-ND were aligned for the primary se-
quences in order that the corresponding peptides residues
would be located in the same orientation. It was found
that the side chains of the center residues of the L-turn,
His6 and D-Phe7 of K-MSH-ND, and the Gln6 and D-Phe7
of [Gln6]K-MSH-ND, have an opposing orientation,
whereas, the Arg8 and Trp9 orientations were similar.
This demonstrates that the sixth and seventh residues of
[Gln6]K-MSH-ND have a mirror image conformation rel-
ative to K-MSH-ND. In addition, the solution structure of
K-MSH-ND demonstrates a type I L-turn composed of
Asp5, His6, D-Phe7 and Arg8, while [Gln6]K-MSH-ND ex-
hibits a type IP L-turn structure comprised of Asp5, Gln6,
D-Phe7 and Arg8.
2.4. Receptor^ligand interactions analyzed by homology
modeling
A putative ligand binding model for the receptor was
constructed by docking the NMR structures of the MSH
analogues with each type of melanocortin receptor model
based on both the mutagenetic data and homology mod-
eling. Most of the results obtained from the mutagenetic
studies [23^25] were clearly explained by this model. In
this homology modeling study, the polar side chain of
His6 in K-MSH-ND was found to interact, as shown in
Fig. 5, with the transmembrane (TM)2 domains of the
melanocortin receptors, namely Glu94 of the MC1R,
Glu94 of the MC3R and Glu100 of the MC4R. Simultane-
ously, the Arg8 residue of this ligand demonstrated an
interaction with the Asp121 residues of the MC1R (Fig.
5A), the Asp121 of the MC3R (Fig. 5B) and the Asp126
of the MC4R (Fig. 5C). Exchanging the sixth residue of K-
MSH-ND to Gln from His6, to form [Gln6]K-MSH-ND,
resulted in a mirror image with an altered orientation of
Fig. 4. Structural comparison of two MSH analogues, K-MSH-ND and [Gln6]K-MSH-ND. The solution structures of K-MSH-ND and [Gln6]K-MSH-
ND, as determined by NMR, were aligned for the primary sequences so that the corresponding residues of each peptide were located in the same orien-
tation.
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the sixth and seventh residues. Since the direction of the
Gln6 residue side chain di¡ered from that of His6, it could
not interact with the TM2 domains of all of the receptors,
whereas the Arg8 residue of [Gln6]K-MSH-ND maintained
the same level of interaction as K-MSH-ND.
The phenyl ring of K-MSH-ND interacted with both the
Cys275 and Ile276 of the MC1R, both the Cys276 and Tyr277
of the MC3R, and both the Cys279 and Phe280 of the
MC4R. These all belong to the TM7 region of each re-
ceptor. However, D-Phe7 of [Gln6]K-MSH-ND could not
interact with any of these residues. Instead, as shown in
Fig. 5B,C, it adjoined the residues of the TM3 domains,
either Ser122 of the MC3R or Ser127 of the MC4R. More-
over, the serine residues of both the MC3R and MC4R
correspond to Val122 of the MC1R (Fig. 5A), which con-
tains a non-polar side chain with two methyl groups. It is
noteworthy that the important residues in the hydropho-
bic binding pockets of the MC1R were clearly di¡erent
Fig. 5. Schematic diagram of the ligand^receptor binding model. The possible interactions between ligands and receptors were elucidated from the com-
plex structures determined by the NMR ligand structure and the homology models of MC1R, MC3R, and MC4R in alphabetical order, A, B, and C,
respectively. The structures of both K-MSH-ND and [Gln6]K-MSH-ND are displayed by thin lines, whereas the receptor residues are displayed by thick
lines.
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Fig. 6. Stereo-view of the homology models for each subtype of the melanocortin receptors. The calculated MC1R, MC3R, and MC4R models are
demonstrated in A, B, and C, respectively. To show the binding cavities clearly, N-terminal regions, exoloops and cytosolic loops have been omitted.
The characters in yellow show ligand residues, and those in green represent receptor residues.
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from those of the other receptors. The Ile276 residue of the
MC1R (Fig. 5A), which is involved in the D-Phe7 binding
site, mutated to Tyr277 in the MC3R (Fig. 5B) and Phe280
in the MC4R (Fig. 5C). On the other hand, the residues of
each receptor at the Trp9 binding cavity lying in the TM6
domains, either Ile264 of the MC1R (Fig. 5A) or Ile265 of
the MC3R (Fig. 5B), were replaced with Tyr268 in the
MC4R (Fig. 5C). Val265 in the MC1R (Fig. 5A), the other
residue interacting with Trp9, was substituted for Ile266 in
the MC3R and Ile269 in the MC4R (Fig. 5C). Overall, as
shown in Fig. 6, all these changes can cause the binding
pocket of the MC4R to be narrower than that of either the
MC1R or the MC3R.
Although the models constructed in this study showed
distinct ligand binding patterns in the three receptors, they
indicated that the TM2, TM3, TM6 and TM7 segments of
these receptors participate in the formation of the binding
pocket for the core sequence of the K-MSH analogues.
These structures are well supported by mutagenetic data,
which demonstrates that TM4 and TM5 are not involved
in ligand binding [26]. Apart from the residues mentioned
above, the e¡ects of other important residues on ligand
binding were also investigated. For example, both Phe258
and His260 in the TM6 segment of the MC1R did not
appear to be involved in the direct ligand interaction,
but rather to be located close to the Trp9 residue of the
core sequence. This indicates that subtle changes of the
local structure at Phe258 and His260 can also in£uence li-
gand binding or receptor activation. Moreover, the Asn277
residues of the MC1R, the His280 residues of the MC3R
and the His283 residues of the MC4R were found to occur
at the bottom of the binding pockets. Furthermore, all of
these residues can operate as hydrogen donors or as ac-
ceptors for hydrogen bonding. Therefore, it is possible
that these residues determine the speci¢city for ligand
binding by forming hydrogen bonds with backbone amide
hydrogen or carbonyl oxygen. The prerequisite character-
istic of a type I L-turn structure may be closely related to
these Asn or His residues.
3. Discussion
By cloning the ¢ve di¡erent melanocortin receptors, the
mechanisms of many known physiologic functions of mel-
anocortins were elucidated. These include central e¡ects
such as the control of motor and sexual behavior, analge-
sia, memory improvement, and antipyretic e¡ects, as well
as peripheral e¡ects, such as powerful anti-in£ammatory
and lipolytic e¡ects. As the melanocortins reveal so many
di¡erent e¡ects through their distinct receptor subtypes,
selective ligands for the given receptor subtypes are re-
quired in order to reduce the undesirable e¡ects of mela-
nocortin. Therefore, structural and functional analyses
based on the interaction between the melanocortin ana-
logues and di¡erent melanocortin receptor subtypes are
important, and will provide valuable information for
structure-based drug design.
In a previous study, the authors reported that [Ahx4]K-
MSH showed a loop structure, while NDP-MSH exhibited
a ‘type I L-turn’-like structure (data unpublished). The
structural change from [Ahx4]K-MSH to NDP-MSH re-
markably enhanced both the receptor binding a⁄nity
and the cAMP-generating activity at the MC1R, MC3R
and MC4R. This result indicated that changes towards a
conformation resembling the type I L-turn could bring
about augmented biological activity in these receptors.
Compared to NDP-MSH, the potency of K-MSH-ND
was relatively weak at all three melanocortin receptors,
which suggests that the residues at the C-terminus of
NDP-MSH are important for enhancing ligand potency
to the MC1R, MC3R and MC4R.
Substitution of the K-MSH-ND His6 residue by Gln,
Trp, Asn, Lys or Tyr resulted in a remarkable reduction
in biological activity. Compared to the MC3R and MC4R,
most of the K-MSH analogues, with the exception of
[Arg6]K-MSH-ND, exhibited signi¢cant decreases in terms
of their binding a⁄nities to the MC1R. With regard to the
cAMP-generating activity, those analogues containing a
positively charged residue at the sixth position, such as
K-MSH-ND, [Arg6]K-MSH-ND and [Lys6]K-MSH-ND,
showed relatively high cAMP-generating activities at all
three receptors. These results suggest that the sixth residue
plays an important role in activating the MC1R, MC3R
and MC4R, and that there is probably some charge inter-
action between the sixth residue of K-MSH-ND and the
three receptors. This is supported by homology modeling
analysis, which suggests that the K-MSH-ND His6 residue
probably interacts with the TM2 Glu residues in all these
receptors (Fig. 5).
K-MSH-ND revealed a tight type I L-turn conforma-
tion, while [Gln6]K-MSH-ND showed a similar structure
to the type I L-turn of K-MSH-ND, the so-called ‘type IP
L-turn’ structure. Even though this di¡erence in backbone
structure is very subtle, [Gln6]K-MSH-ND showed an ap-
proximate 10 000-fold reduction in biological activity com-
pared to K-MSH-ND at the MC1R, while the biological
potency of both oligopeptides was comparable to that at
both the MC3R and MC4R. In a previous study [15], both
[Lys6]K-MSH-ND and [Gln6]K-MSH-ND(6^10) were
shown to have Q-turn conformations and both of them
were found to have reduced receptor binding and
cAMP-generating activity at the MC1R. Therefore, the
more the structure of an K-MSH-ND-derived analogue
diverges from the type I L-turn, the less its preference
for the MC1R. However, using homology modeling anal-
ysis, it was found that the binding pocket of the MC1R
was much broader than that of the MC4R (Fig. 6). This
indicates that the MC1R might be signi¢cantly more tol-
erant to subtle changes in ligand conformation. However,
[Gln6]K-MSH-ND could not activate this receptor e¡ec-
tively. Therefore, subtle di¡erences in the backbone struc-
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ture alone cannot explain the di¡erent biological potency
of [Gln6]K-MSH-ND at the MC1R.
The selectivity or biological potencies of a diverse num-
ber of peptides have been examined both in terms of their
backbone structures and their side chain characteristics
[16^21]. The backbone structures of K-MSH-ND and
[Gln6]K-MSH-ND are quite similar, whereas their side
chain orientations are di¡erent and it was determined
that [Gln6]K-MSH-ND is a mirror image analogue of K-
MSH-ND. To de¢ne how such conformational di¡erences
could result in such great di¡erences in biological activity
at the MC1R, this study compared their individual bind-
ing patterns to these receptors. Molecular modeling anal-
ysis revealed that the positively charged His6 residue of K-
MSH-ND interacts with the negatively charged Glu resi-
dues in the TM2 regions of the three melanocortin recep-
tors, whereas the Gln6 in [Gln6]K-MSH-ND does not (Fig.
5). This indicates that the alteration in the latter’s side
chain orientation, which lacks a charge interaction with
the TM2 regions, is responsible for the signi¢cant reduc-
tion in biological activity at these receptors. Hydrophobic
binding pockets in each receptor are composed of diverse
hydrophobic amino acids, which may also confer binding
activity or speci¢city. NMR analysis revealed that the D-
Phe7 residue of [Gln6]K-MSH-ND to be a mirror image of
the corresponding K-MSH-ND position. This directional
displacement changed the D-Phe7 binding sites of all re-
ceptors from the hydrophobic binding domain of the TM7
region to that of the TM3 regions as shown in Fig. 5.
Therefore, the altered receptor binding patterns of the
[Gln6]K-MSH-ND D-Phe7 residues may also explain the
decreased biological potency at all the receptors.
None of the TM2 regions in any of the three receptor
subtypes would bind to [Gln6]K-MSH-ND, because of the
altered orientation of Gln6. However, the Arg8 and Trp9
binding sites of all three receptors exhibited similar bind-
ing. Therefore, the changed D-Phe7 orientation in [Gln6]K-
MSH-ND was considered to be most likely responsible for
the signi¢cant decrease in biological activity at the MC1R,
while such a change was tolerable at both the MC3R and
MC4R. As expected, homology modeling showed that D-
Phe7 in [Gln6]K-MSH-ND could not contact the hydro-
phobic binding region of TM7, as observed in K-MSH-
ND. Instead it adjoined to the residues of the TM3 do-
mains in all three receptors. Compared to the altered bind-
ing sites of the MC3R (Ser122) and MC4R (Ser127), it was
apparent that, in the MC1R, these Ser residues correspond
to Val122, which contains two methyl groups. Since the
phenyl ring of [Gln6]K-MSH-ND coincidentally overlaps
with these two bulky groups, it is believed that its inter-
action with the valine residue of the MC1R, as opposed to
the serine residue of either the MC3R or the MC4R, in-
duces steric hindrance with the D-Phe7 in the ligand. Fur-
thermore, this repulsion interaction between these two res-
idues results in the relatively low a⁄nity of [Gln6]K-MSH-
ND to the MC1R.
Although this study has presented a strategy for devel-
oping a melanocortin analogue with minimized MC1R-
selectivity, the potential optimal structure of the ligand
contributing to MC3R or MC4R selectivity has not been
elucidated. By homology modeling analysis, the binding
pocket of the MC4R was determined to be narrower
than that of either the MC1R or the MC3R. Other studies
have also reported that the MC4R prefers cyclic ligands,
whereas the MC1R and the MC3R are inclined to interact
with linear species [27]. A ligand with a cyclic conforma-
tion tends to form a tight rigid structure. Therefore, it is
likely that a ¢xed conformation of cyclic ligands is advan-
tageous in terms of entering the narrow binding pocket of
the MC4R, while the £exibility of linear ligands is best
suited to cover the broad binding pockets of the MC1R
and the MC3R.
In conclusion, the results of this study have suggested
that minimizing MC1R activation simultaneously with
preserving the comparable MC3R and MC4R selectivity
may be achieved by modifying the D-Phe7 side chain ori-
entation of K-MSH-ND, while maintaining a ‘type I L-
turn’-like structure. In addition, the way the side chains
of the K-MSH analogues interact with the melanocortin
receptor subtypes was determined.
4. Signi¢cance
Many of the e¡ects of melanocortin peptides are medi-
ated via speci¢c melanocortin receptor subtypes. Until
now, most K-MSH analogues have not shown signi¢cant
discrimination, and bind preferably to the MC1R, the
MC3R and the MC4R with a high a⁄nity. For this rea-
son, the structural and functional analyses of the ligand^
receptor interactions are essential for developing selective
ligands to the speci¢c melanocortin receptor subtypes, es-
pecially, to the MC3R and/or the MC4R. This report
describes the biological activity of K-MSH-ND and the
K-MSH-ND-derived analogues at the MC1R, the MC3R
and the MC4R. Furthermore, it details the NMR struc-
tural characteristics, and demonstrates the interactions be-
tween the K-MSH analogues and the melanocortin recep-
tor subtypes by receptor homology modeling analysis. The
most signi¢cant ¢nding was that [Gln6]K-MSH-ND exhib-
its a type IP L-turn, which is similar to the type I L-turn
structure of K-MSH-ND. However, [Gln6]K-MSH-ND
had approximately 10 000 times less biological activity
than K-MSH-ND at the MC1R, while the potencies of
the two analogues were comparable at both the MC3R
and the MC4R. These results can be explained by a struc-
tural di¡erence in the side chain orientations of the sixth
and seventh residues of [Gln6]K-MSH-ND, which are mir-
ror images of K-MSH-ND. The ¢ndings presented here
suggest that minimizing MC1R selectivity whilst preserv-
ing the comparable potency for the MC3R and the MC4R
may be achieved by modifying the D-Phe7 orientation of
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K-MSH-ND, while maintaining a ‘type I L-turn’-like struc-
ture. These results will assist in understanding of the struc-
ture^activity relationships of the K-MSH analogues and
provide a future direction for developing potent MC4R-
and/or MC3R-selective K-MSH analogues.
5. Materials and methods
5.1. Chemicals
All media and sera for cell cultivation were purchased from
Gibco-BRL (USA). The NDP-MSH and other chemicals were
purchased from Sigma (USA), unless otherwise speci¢ed.
5.2. Peptide synthesis
The peptides used in this study were synthesized at the Korea
Basic Science Institute (Seoul, South Korea) using the solid phase
approach, and puri¢ed by high performance liquid chromatogra-
phy (HPLC, Delta PAK 15 W C18 300 Aî 3.9 mmU150 mm
column, detection at 240 nm). Peptide sequences were assembled
with a Milligen 9050 (Fmoc Chemistry), and peptide molecular
weights were con¢rmed by mass spectroscopy. A reagent mixture
(88% tri£uoroacetic acid, 5% phenol, 2% triisopropylsilane, and
5% H2O) was used for de-protection. The raw peptides formed
were puri¢ed by HPLC.
5.3. Cell culture and stable transfections
The CHO cells were maintained in a F-12 medium (with glu-
tamine) supplemented with 10% of fetal bovine serum, 100 units/
ml penicillin G sodium, 100 Wg/ml streptomycin sulfate and 0.25
Wg/ml of amphotericin B. The cells were incubated in a 100-mm
culture dish at 37‡C in humidi¢ed air containing 5% CO2. For
transfections, the hMC1R, rMC3R and hMC4R cDNAs were
cloned into the expression vector pcDNA I/neo. The cells were
generally at 50% con£uence on the day of transfection, this pro-
cedure being carried out using the calcium phosphate method, as
described previously [15]. Brie£y, the cells were fed with fresh
complete culture medium containing 20 mM HEPES and incu-
bated in a 95% air/5% CO2 mixture. After 3^4 h, the medium was
discarded and 5 ml of calcium phosphate^DNA precipitate con-
taining 25 Wg of DNA, 124 mM CaCl2, 140 mM NaCl, 25 mM
HEPES and 1.41 mM of Na2HPO4 (pH 7.12) was added. The
cells were then incubated for 4 h in a 97% air/3% CO2 mixture,
washed with phosphate-bu¡ered saline (PBS, 137 mM NaCl, 2.68
mM KCl, 4.3 mM N2HPO4, and 1.47 mM KH2PO4, at pH 7.12),
and shocked with a glycerol bu¡er (15% glycerol, 140 mM NaCl,
25 mM HEPES and 1.41 mM Na2HPO4, at pH 7.12). The cells
were again washed with PBS, and incubated for an additional 36^
48 h in complete F-12 medium. They were then re-cultured in
complete F-12 medium containing 0.5 mg/ml G418 (Geneticin;
Life Technologies) until G418-resistant colonies were generated.
The G418-resistant colonies were collected and subcultured for at
least 10^14 days. Finally, the hMC1R-, rMC3R- and hMC4R-
expressing cells were identi¢ed by screening more than 15 colo-
nies and con¢rmed by assaying the NDP-MSH-induced cAMP
accumulation.
5.4. Binding study
The iodinated NDP-MSH (the NDP-MSH sequence is Ser-Tyr-
Ser-Ahx-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val), and the 125I-
(iodotyrosyl2)-[Ahx4, D-Phe7]K-MSH, was prepared by a modi¢-
cation of chloramine-T method [15]. 1 mCi (10 Wl) of Na125I
(Amersham) was added to 5 Wg of NDP-MSH in 100 Wl of a
200 mM sodium phosphate bu¡er (pH 7.2). 20 Wl of 2.8 mg/ml
chloramine T solution in a 200 mM sodium phosphate (pH 7.2)
was then added and the mixture allowed standing for 15 s, fol-
lowed by the addition of 50 Wl of 3.6 mg/ml of sodium metabi-
sulfate to quench the reaction. The reaction mixture was diluted
with 1 ml of 0.1% bovine serum albumin (BSA) solution contain-
ing 0.1% of tri£uoroacetic acid and puri¢ed using a C18 Sep-Park
cartridge (Waters) and Sephadex G25 gel ¢ltration chromatogra-
phy. The puri¢ed reagents were collected in 0.5-ml aliquots in
Sigmacote-coated sterile glass tubes containing 100 Wl of the
PBS bu¡er with 0.1% BSA. For the binding assays, the stably
transfected CHO cells were plated 48 h prior to the experiment in
24-well culture plates (Falcon Plastics) at a density of 5U104 per
well until they were 90^95% con£uent on the day of the assay.
The maintenance media was removed and the cells were washed
twice with washing bu¡er (50 mM Tris, 100 mM NaCl, 5 mM
KCl, and 2 mM CaCl2, at pH 7.2), then immediately incubated at
37‡C for 2 h with 0.25 ml binding bu¡er per well (50 mM Tris,
100 mM NaCl, 5 mM KCl, 2 mM CaCl2, 5% Hanks’ balanced
salt solution, and 0.5% BSA, at pH 7.2) containing 100 000 cpm
(V2 nM) of [125I]NDP-MSH and the appropriate concentrations
of the unlabeled competing ligand. After incubation, the plates
were placed on ice for 15 min, washed twice with 0.5 ml of an ice-
cold binding bu¡er, and detached from the plates by twice £ush-
ing with 0.5 ml of 0.05 M NaOH (¢nal volume: 1 ml). The radio-
activity was then determined (Workman automatic Q counter) and
the data analyzed with a software package suitable for radioli-
gand binding data analysis (GraphPad Prism Program). Non-
speci¢c binding was determined by measuring the amount of
bound [125I]NDP-MSH remaining in the presence of 1035 M un-
labeled NDP-MSH, while the speci¢c binding was calculated by
subtracting the non-speci¢cally bound radioactivity from the to-
tal bound radioactivity. The Ki (nM) values were calculated using
the Cheng and Pruso¡ equation [28], and are reported as a
mean þ S.E.M. All of the binding assays were performed in trip-
licate wells and repeated twice.
5.5. cAMP assay
The intracellular cAMP levels were determined using a previ-
ously described method [15]. The CHO cells over-expressing the
MC1R, MC3R or MC4R were grown to 90^95% con£uence in
24-well plates. The cell culture media were exchanged with com-
plete F-12 medium containing 10% fetal bovine serum 3^4 h
before the cells were treated with the peptides. For the assays,
the media were removed and the cells were then washed with 0.5
ml of cAMP-generating medium (10% fetal bovine serum, 2 mM
IBMX, 0.1% BSA, 20 mM HEPES, and 0.002% ascorbic acid in
F-12 Medium). 0.25 ml of the cAMP-generating medium contain-
ing various peptide concentrations was added and the cells were
incubated for 30 min at 37‡C. At the completion of this incuba-
tion, the medium was completely discarded, and the cells were
then frozen at 370‡C for 30 min and thawed at room temper-
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ature for 15^20 min, the freezing^thawing process was repeated
twice. The cells were detached from the plates with 1 ml of a 50
mM HCl solution per well, transferred to a 1.5-ml Eppendorf
tube, and then centrifuged at 1900Ug for 10 min. The superna-
tants were diluted 50-fold with acetate bu¡er and the cAMP
concentrations were measured using a cAMP 125I RIA kit (Dia-
sorin, USA), according to the assay instructions. The mean val-
ues of the collected data were ¢tted to a sigmoid curve with a
variable slope factor by non-linear regression in a GraphPad
Prism. The EC50 (nM) values are presented as a mean þ S.E.M.
All the cAMP assays were performed in triplicate wells and re-
peated twice.
5.6. NMR experiments and structure determination
All NMR samples were prepared using the method described
previously [14,15]. The NMR experiments were carried out at
10‡C on a Bruker DRX-500 spectrometer equipped with a triple
resonance probe with triple axis gradient coils. The NMR spectra
were recorded over temperatures ranging from 5 to 25‡C in order
to calculate the temperature coe⁄cients. Pulsed-¢eld gradient
(PFG) techniques were used for all H2O experiments to suppress
the solvent signals. 2D total correlation spectroscopy (TOCSY)
with an MLEV-17 mixing pulse of 69.7 ms was then performed,
as was the 2D nuclear Overhauser e¡ect spectroscopy (NOESY)
with mixing times of 100^600 ms. 2D rotating-frame Overhauser
e¡ect spectroscopy (ROESY) with 100^800-ms ROE mixing times
was also performed in a D2O solution. 2D double-quantum-¢l-
tered correlated spectroscopy (DQF-COSY) spectra were col-
lected in H2O to obtain the vicinal coupling constants. A series
of 1D NMR measurements were obtained to identify the slowly
exchanging amide hydrogen resonances in freshly prepared D2O
solutions after lyophilization of the H2O sample. All NMR ex-
periments were performed in the phase-sensitive mode using the
time proportional phase incrementation (TPPI) method with 2048
data points in the t2 and 256 in the t1 domains. NMR data was
processed using the XWIN-NMR (Bruker Instruments) software,
and the processed data analyzed using the Sparky 3.60 software
developed at UCSF on a Silicon Graphics Indigo2 workstation.
The initial structures were generated from distance geometry
(DG) employing a re¢nement protocol described by Lee et al.
[29]. The K-MSH-ND and [Gln6]K-MSH-ND NOESY spectra
yielded 47 and 58 NOE constraints, respectively. These distance
restraints were assigned as strong, medium, or weak under the
criterion of cross-peak volumes in the NOESY spectra. All cate-
gories had a lower limit of 1.8 Aî , with upper limits of 2.7, 3.3,
and 5.0 Aî for strong, medium or weak intensities, respectively.
The constraints for the dihedral angles of these peptides were also
deduced on the basis of the 3JHNK coupling constants from 2D
DQF-COSY spectra in H2O. The structure calculations were per-
formed using hybrid DG and the dynamically simulated-anneal-
ing protocol with an X-PLOR 3.81 (Biosym/Molecular Simula-
tions, Inc.) program on a Silicon Graphics Indigo2 workstation.
5.7. Comparative modeling of MCRs
The TM regions of the receptor molecules were determined
from both the sequence alignment and the topology prediction
data of hMC1R, rMC3R and hMC4R [30,31]. The primary se-
quence alignment data was obtained from Haskell-Luevano et al.
[32]. The molecular topology prediction of the receptors was per-
formed using the Tosts method on an EMBL protein-predict
server and this data was aligned with the bovine rhodopsin se-
quence. As bovine rhodopsin is one of the typical members of the
G-protein coupled receptor families (GPCRs), which include the
melanocortin receptors, it was selected as an excellent template of
comparative modeling [33^35]. Initially, the MCR template struc-
tures were generated for only heavy atoms. Molecular models of
the TM helix bundles were constructed with an orientation such
that the helical axis was coincident with the corresponding axis in
a modeled rhodopsin template [36]. These models were further
re¢ned by an energy minimization procedure. The force ¢eld used
for the modeling calculations was cv¡ (de¢nite cv¡) in the Dis-
cover Module of the Insight II program (MSI Inc.) on a SGI
Indigo2 workstation. The 3D structures of the receptor molecules
were completed by replacing the helical segments of the bovine
rhodopsin with the melanocortin receptor sequences using the
Modeler program [37]. This was followed by rearranging the helix
orientations using the reported method [31].
After modeling, some correction criteria for the helix orienta-
tion were used to properly rearrange the TM sequences. First,
previous reports on site-speci¢c mutagenesis, which gives the in-
formation on the location of critical residues, were used. As dis-
cussed in the result section, Glu94, Asp121, Phe258, and His260
should not face outward. Therefore, the TM sequences were re-
arranged to the template only in the range of 1 helix turn.
To validate the local structures of helices regions, the Eisenberg
hydrophobic moment was calculated ¢tting the angles of the
K-helix [38]. The hydrophobic interface should be located at
105 þ 15‡ on the axis of the helical wheel because a typical K-helix
possesses 3.4 residues per turn. The most of individual segments
of the TM regions were satis¢ed to this maximum hydropathy
angle, but the TM4 regions were not. The sequence selection of
the TM4 regions were based on a sequence alignment as well as a
hydropathy plot, and no other data were available because these
regions were not involved in the MSH activity. The unusual ori-
entation of TM4 regions was considered as the e¡ect of other
helices, especially TM3. The unique axis of the TM3 helix may
cause an interaction with its closest neighbor, TM4, and this
interaction can have a synergistic e¡ect beyond the sequence it-
self. Considering the research objectives, no further investigation
into this region was required. However, the structural role of
TM1, TM4 and TM5 regions, which are not involved in MSH
activity, were studied.
Previous mutagenetic and biochemical data also provided in-
formation on the relative side chain orientations of the critical
amino acids in the receptor molecule [23,39]. After all the coor-
dinates were successfully arranged, a conformational search algo-
rithm for the other side chains was performed using the side
chain rotamer library. The ¢nal structures were evaluated with
the PROCHECK program [40]. The TM residues in the allowed
region of the Ramachandran plot were in 99.3% for the MC1R,
99.3% for the MC3R, and 100% for the MC4R. The overall G-
factors were 30.4 for the MC1R, 30.37 for the MC3R, and
30.32 for the MC4R. The receptor^ligand complex structures
of the MC1R, MC3R and MC4R were ¢nally generated by a
ligand docking procedure based on the mutagenetic and NMR
data.
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